Date of filling in this questionnaire or last update: 19/05/2020
1. IDENTIFICATION & BASIC DESCRIPTION
Cohort name
  Milan Policlinico Healthcare Workers (POLIMI-HCW)
Country
 

  • Italy

Name
  Dario Consonni
Institution
  Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
Email
  dario.consonni@unimi.it
Phone
  +390255032634
Personal website
  https://www.policlinico.mi.it/i-nostri-professionisti/profilo/1027/consonni-dario
Name of committee
  Policlinico Hospital Review Board
Contact Principal Investigator (name)
  Dario Consonni
Participation in pooled analyses
 

  • The cohort is potentially interested in participating in pooled analyses of (European) occupational cohort studies (note pooled analyses also includes remote decentralized analyses that would not require any transfer of primary data as well as meta-analyses).

Main aim of cohort, please briefly describe the main objectives of the cohort
  To examine occurrence of SARS-CoV-2 infection among healthcare workers
Study design (please select as many as appropriate)
 

  • Prospective cohort

Source population (please select as many as appropriate)
 

  • Industry / occupation -based

Comparators (please select as many as appropriate)
 

  • Internal study population

Inclusion criteria
  Hospital employed
Year(s) of enrollment
 

From To
2020

Enrollment
  Ongoing
Age range at entry (subcohort)
 

Minimum Maximum Mean Please describe
20 75

Men at enrollment
  1500
Women at enrollment
  3500
2. OUTCOME FOLLOW-UP
Type of data for outcome follow-up (please select as many as appropriate)
 

  • Other (specify)

Specify: Other
 

  • SARS-CoV-2 nasopharyngeal swab and serum antibodies

3. OCCUPATIONAL EXPOSURES
Source of exposure data collected (please select as many as appropriate)
 

  • Questionnaire, Personal (Self-reporting or interview)
  • Job-employment records

Occupational history/time frame
  Current, at enrollment
Occupational coding performed
  No
4. OUTCOMES EVALUATED
Baseline - type of outcome data collected (select more than one if applicable)
 

  • Biomarker (specify)

Specify: Biomarker
  SARS-CoV-2 RNA measured via RT-PCR + serum IgG antibodies
Follow-up - type of outcome data collected (select more than one if applicable)
 

  • Biomarker (specify)

Specify: Biomarker
  SARS-CoV-2 RNA measured via RT-PCR + serum IgG antibodies
Outcome type (please select as many as appropriate)
 

  • Morbidity

Diagnostic groups based on ICD10
 

  • B Viral infections, type of microorganisms*

B Viral infections, type of microorganisms
 

  • Other viral infections, please state

B Viral infections, type of microorganisms | Other (specify)
  SARS-CoV-2
Other health related outcomes
 

  • Other (specify)

Specify: Other
  PTSD
5. BIOLOGICAL SAMPLES & ANALYSIS
Biological samples collected
 

  • Blood
  • Other

Specify: Other
  Nasopharyngeal mucus
Biological processing
 

  • RNA

Genetic and other lab analyses
 

  • Biomarkers (specify)

Specify: Biomarkers
  SARS-CoV-2 IgG serum antibodies
6. Other Information
 

  • Anthropometry
  • Demographics
  • Medical history
  • Smoking

Possibility for linkage to data registries/data enrichment via data linkage
 

  • Hospital discharge